Moderna said Friday that Pfizer and BioNTech's vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, Spikevax.
The findings reflect the changing nature of the pandemic, in which the vast majority of people already have some protection against the virus due to vaccination or prior infection.
Pfizer and French biotech Valneva are aiming to avoid previous pitfalls in developing a new vaccine to protect both adults and kids as young as 5 from the most common Lyme strains on two continents.
U.S. FDA advises manufacturers to add a spike protein component of the Omicron subvariants BA.4 and BA.5 to their prototype vaccines for fall boosters.
More than 325 days of non-compliant closures. Insurance billing for prescriptions that patients could not pick up. Vaccines booked five minutes apart when only one pharmacist was onsite. These are just some of the accusations filed against Walgreens by Vermont's prosecuting attorney.
HRA Pharma's application on Monday sets up a high-stakes decision for health regulators amid legal and political battles over women's reproductive health.
Deputy Chief Public Health Officer Howard Njoo told a news conference this morning that Health Canada continues to review Moderna's application for a vaccine to protect children between six months and five years old.
